Dr. Zong has been the Vice President of Production, Research & Development for EXUMA Biotech since December 2018. He was previously the Vice President of Production, Research & Development for PerHum Therapeutics from June 2017 to November 2018 where he was responsible for CAR-T manufacturing related production, warehouse management, purchasing, cell process R&D, CRO collaboration and clinical trial-related molecular diagnostic technologies. He was the Chief Scientific Officer of Tofflon Healthcare from April 2016 to June 2017, where he led the R&D team to development and preclinical studies for the universal CAR-T product targeting hematologic malignancies and solid tumors. Dr. Zong earned his B.M. in Preventative Medicine and Ph.D. in Biochemistry and Molecular Biology from Shanghai Medical College of Fudan University.
Hongliang Zong, Ph.D.VP Production, Research & Development